Zytokinproduktion

• Literatur

• 1 Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten C. et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881-922.
• 2 Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M. et al. Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry 2004; 37: 243-65.
• 3 Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Davis JP. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet 1981; 01: 1017-21.
• 4 Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil JC, Arnaud P. Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol Pharm Bull 2002; 25: 1600-3.
• 5 Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008; 181: 5396-404.
• 6 Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 09: 46-56.
• 7 Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13: 16-34.
• 8 Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry 2010; 18: 172-6.
• 9 Hamelryck TW, Dao-Thi MH, Poortmans F, Chrispeels MJ, Wyns L, Loris R. The crystallographic structure of phytohemagglutinin-L. J Biol Chem 1996; 271: 20479-85.
• 10 Himmerich H, Fulda S, Sheldrick AJ, Plümäkers B, Rink L. IFN-gamma reduction by tricyclic antidepressants. Int J Psychiatry Med 2010; 40: 413-24.
• 11 Himmerich H. et al. Regulatory T cells increased while IL-1 decreased during antidepressant therapy. J Psychiatr Res 2010; 44: 1052-7.
• 12 Himmerich H, Schönherr J, Fulda S, Sheldrick AJ, Bauer K, Sack U. Impact of antipsychotics on cytokine production in-vitro. aJ Psychiatr Res. 2011 Epub ahead of print.
• 13 Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002; 05: 401-12.
• 14 Kim J, Urban RG, Strominger JL. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 1994; 266: 1870-4.
• 15 Kirchner H, Kleinicke C, Digel W. A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods 1982; 48: 213-9.
• 16 Kubera M, Kenis G, Bosmans E, Kajta M, BastaKaim A, Scharpe S. et al. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol 2004; 04: 185-92.
• 17 Leung S, Liu X, Fang L, Chen X, Guo T, Zhang J. The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol 2010; 07: 182-9.
• 18 Liu H, Leung BP. CD4+CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol 2006; 33: 519-24.
• 19 Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL. et al. Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection. Clin Transplant 2003; 17: 69-74.
• 20 Miller DB, O’Callaghan JP. Depression, cytokines, and glial function. Metabolism 2005; 54: 33-8.
• 21 Mutschler E, Geisslinger G, Kroemer HK, SchäferKorting M. Arzneimittelwirkungen. 8. Aufl. Stutt- gart: Wissenschaftliche Verlagsgesellschaft 2001; 937.
• 22 Pickering M, Cumiskey D, O’Conner JJ. Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 2005; 90: 663-70.
• 23 Piletz JE, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H. et al. Pro-inflammatory biomakers in depression: Treatment with venlafaxine. World J Biol Psychiatry 2008; 31: 1-11.
• 24 Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201-17.
• 25 Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Cytokine production and serum proteins in depression. Scand J Immunol 1995; 41: 534-8.
• 26 Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH. et al. A detailed examination of cytokine abnormalities in major depressive disorder. European Neuropsychopharmacology 2008; 18: 230-3.
• 27 Stølevik SB, Nygaard UC, Namork E, Granum B, Pellerud A, van Leeuwen DM. et al. In vitro cytokine release from human peripheral blood mononuclear cells in the assessment of the immunotoxic potential of chemicals. Toxicol In Vitro 2011; 25: 555-62.
• 28 Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A. et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006; 367: 29-35.
• 29 Wagner-Jauregg J. Über die Einwirkung fieberhafter Erkrankungen auf Psychosen. JB Psychiatr 1887; a7: 94-131.
• 30 Whitrow M. Julius Wagner-Jauregg (1857–1940). J Med Biogr 1993; 01: 137-43.
• 31 Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006; 31: 2121-31.